| CTRI Number |
CTRI/2024/10/075552 [Registered on: 21/10/2024] Trial Registered Prospectively |
| Last Modified On: |
18/10/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Ayurveda |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
A CLINICAL STUDY TO EVALUATE THE EFFECT OF AYURVEDIC MEDICINE ON GARBHASHAYA SHUDDHI IN SUTIKAVASTHA |
|
Scientific Title of Study
|
Randomised controlled clinical trial of panchakola churna and latakaranj churna for garbhyashaya shuddhi in sutikavastha. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Trupti Pitambar Bhosale |
| Designation |
PG Scholar |
| Affiliation |
Tilak Ayurveda Mahavidyalaya |
| Address |
Department of streeroga and Prasutitantra Tilak Ayurved Mahavidhyalaya Rasta Peth Pune
Pune MAHARASHTRA 411011 India |
| Phone |
9604468111 |
| Fax |
|
| Email |
truptibhosale2121@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DR RAHUL JAYPRAKASH GARUDKAR |
| Designation |
ASSOCIATE PROFESSOR |
| Affiliation |
Tilak Ayurved Mahavidhyalaya Rasta Peth Pune |
| Address |
Department of streeroga and Prasutitantra Tilak Ayurved Mahavidhyalaya Rasta Peth Pune
Pune MAHARASHTRA 411011 India |
| Phone |
9822777367 |
| Fax |
|
| Email |
drrahulgarudkar@yahoo.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Rahul Jayprakash Garudkar. |
| Designation |
Associate professor |
| Affiliation |
Tilak Ayurved Mahavidhyalaya Rasta Peth Pune |
| Address |
Department of streeroga and Prasutitantra Tilak Ayurved Mahavidhyalaya Rasta Peth Pune
Pune MAHARASHTRA 411011 India |
| Phone |
9822777367 |
| Fax |
|
| Email |
drrahulgarudkar@yahoo.com |
|
|
Source of Monetary or Material Support
|
| Tilak Ayurved Mahavidhyalaya And Seth Tarachand Ramnath Charitable Ayurvedic Hospital Rasta Peth Dist-Pune 411011 ,Maharashtra,India |
|
|
Primary Sponsor
|
| Name |
Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurved Hospital |
| Address |
Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurved Hospital,Rasta Peth,Pune 411011,maharashtra,India |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Trupti Pitambar Bhosale |
Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurved Hospital |
OPD NO 11 AND IPD of Department of streeroga and prasutitantra Rasta peth Pune MAHARASHTRA |
9604468111
truptibhosale2121@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Ethics Committee, Tilak Ayurved Mahavidyalaya ,Pune |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:N859||Noninflammatory disorder of uterus, unspecified. Ayurveda Condition: SUTIKAROGAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Panchakol Churna, Reference: Sushruta sharira sthana , Route: Oral, Dosage Form: Churna/ Powder, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Samudga, Duration: 21 Days, anupAna/sahapAna: Yes(details: -Gudaushanodaka), Additional Information: -500mg BD for 21 days | | 2 | Comparator Arm | Drug | Classical | | (1) Medicine Name: Latakaranj churna, Reference: Bhavprakash Nighantu, Route: Oral, Dosage Form: Churna/ Powder, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Samudga, Duration: 21 Days, anupAna/sahapAna: Yes(details: -jala), Additional Information: -500 mg BD for 21 days |
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
40.00 Year(s) |
| Gender |
Female |
| Details |
1) Patient with normal delivery
2) Age of patient between 18 to 40 year
3) Irrespective of Parity |
|
| ExclusionCriteria |
| Details |
1) Case with cesarian delivery
2) High risk pregnancy with systemic diseases
3) case with PIH, Pre-Eclampsia, PPH
4) Pregnancy with Heart disease and Severe Anemia
|
|
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Garbhashaya shuddhi, Samyak agni, Prakruta stanya utpatti |
1st week ,2nd week ,3rd week |
|
|
Secondary Outcome
|
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
29/10/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Sutika kala is very critical life in women life, as she is Kshati vrani, durbala, dhatukshaya and agnimandya so because of this change physiological state she becomes suceptible to various infection .it is necessary to prevent those infection and puerperal sepsis and ultemately maintan her health throught post-partum period.This Work If proved to be effective on garbhashaya shuddhi in sutikavastha , will be beneficial for society as it will lead to healthy motherhood. |